Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$30.66 USD

30.66
5,943,060

-1.41 (-4.40%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $30.64 -0.02 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (234 out of 246)

Industry: Instruments - Scientific

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Bruker (BRKR) Q1 Earnings & Revenues Beat, Margins Expand

by Zacks Equity Research

Bruker's (BRKR) Q1 benefits from improved European revenues, rising year over year in high-single digits.

    Nabaparna Bhattacharya headshot

    Is the Tax Repeal Only Glitter and No Gold for MedTech?

    by Nabaparna Bhattacharya

    While the MedTech fraternity is hopeful about the latest MedTech tax repeal, we would like to draw your attention to the slump in share price and net margin figures following the tax's abolition in 2015.

      Zacks Equity Research

      Bruker (BRKR) Down 9.3% Since Earnings Report: Can It Rebound?

      by Zacks Equity Research

      Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

        Zacks Equity Research

        Bruker (BRKR) Beats on Q4 Earnings & Revenues, Issues View

        by Zacks Equity Research

        Bruker (BRKR) registers organic revenue growth on strength in NANO and BEST platforms in Q4.

          Zacks Equity Research

          Cerner Gains Momentum in HCIT Space Amid Tough Competition

          by Zacks Equity Research

          Cerner (CERN) continues to benefit from the ongoing demand for its core solutions and services driven by the HITECH Act.

            Zacks Equity Research

            Abaxis Well Poised on Solid Prospects, Competition Rife

            by Zacks Equity Research

            Abaxis' (ABAX) new sales and marketing strategies boost investors' confidence.

              Zacks Equity Research

              Becton, Dickinson (BDX) a Step Closer to Bard Acquisition

              by Zacks Equity Research

              Becton, Dickinson and Company (BDX) gets FTC's nod for the acquisition of C. R. Bard.

                Zacks Equity Research

                IRadimed (IRMD) Hits 52-Week High: What's Driving the Stock?

                by Zacks Equity Research

                Positive tidings on the regulatory front drive IRadimed's (IRMD) growth. The company's solid guidance is also encouraging.

                  Zacks Equity Research

                  Zimmer Biomet Strong on Positive Data From PROGRESS II Study

                  by Zacks Equity Research

                  Zimmer Biomet (ZBH) consistently endeavors to improve its knee business.

                    Zacks Equity Research

                    Here's Why You Should Invest in Masimo (MASI) Right Now

                    by Zacks Equity Research

                    Masimo (MASI) rides high on its solid guidance. The company's recent FDA approval is also encouraging.

                      Zacks Equity Research

                      Haemonetics Banks on Hospital Business, Competition Rife

                      by Zacks Equity Research

                      For fiscal 2018, Haemonetics (HAE) expects the Hospital business to grow 7-10%.

                        Zacks Equity Research

                        The Zacks Analyst Blog Highlights: Bruker, Dana, Fair Isaac, Skechers and SodaStream

                        by Zacks Equity Research

                        The Zacks Analyst Blog Highlights: Bruker, Dana, Fair Isaac, Skechers and SodaStream

                          David Bartosiak headshot

                          5 Strong Buy Stocks Gaining Momentum

                          by David Bartosiak

                          These five strong buy stocks are at highs and still gaining momentum

                            Zacks Equity Research

                            Zacks.com highlights: Natus Medical, GoPro, Enviva Partners and Bruker

                            by Zacks Equity Research

                            Zacks.com highlights: Natus Medical, GoPro, Enviva Partners and Bruker

                              Tirthankar Chakraborty headshot

                              4 Top Stocks With Earnings Acceleration to Buy Now

                              by Tirthankar Chakraborty

                              Studies have shown that a majority of stocks had seen acceleration in earnings before an uptick in the stock price.

                                Zacks Equity Research

                                Bruker's NANO Grows Strong, MERLIN Buyout Holds Promise

                                by Zacks Equity Research

                                Bruker's (BRKR) recent acquisition of Germany-based MERLIN buoys optimism for its growth within MALDI Biotyper business.

                                  Zacks Equity Research

                                  Bruker (BRKR) in Focus: Stock Moves 6.5% Higher

                                  by Zacks Equity Research

                                  Bruker (BRKR) was a big mover last session, as the company saw its shares rise nearly 7% on the day.

                                    Zacks Equity Research

                                    Bruker (BRKR) Q3 Earnings & Revenues Beat Estimates, View Up

                                    by Zacks Equity Research

                                    Bruker (BRKR) raises 2017 guidance. The year-over-year increase in Q3 revenues encourages.

                                      Zacks Equity Research

                                      Bruker (BRKR) at a 52-Week High: What's Driving the Stock?

                                      by Zacks Equity Research

                                      The new 52-week high of Bruker (BRKR) came on the back of several new initiatives, the most recent one being the introduction of the new CE-IVD marked Fungiplex Candida fast diagnostic assay.

                                        Zacks Equity Research

                                        Bruker (BRKR) Strong on Product Launches Amid Currency Woes

                                        by Zacks Equity Research

                                        Bruker (BRKR) continues to see solid contributions from NMR and Nano businesses. Also, a raised guidance is indicative of brighter prospects.

                                          Zacks Equity Research

                                          Why Is Bruker (BRKR) Up 2.3% Since the Last Earnings Report?

                                          by Zacks Equity Research

                                          Bruker (BRKR) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                            Zacks Equity Research

                                            Bruker Launches D8 VENTURE BIOTOOLS for Home Laboratory

                                            by Zacks Equity Research

                                            Bruker's (BRKR) D8 VENTURE BIOTOOLS for laboratory macromolecular crystallography has some latest features in terms of source, detector and sample handling technology.

                                              Zacks Equity Research

                                              Bruker (BRKR) Q2 Earnings & Revenues Beat Estimates, View Up

                                              by Zacks Equity Research

                                              Bruker (BRKR) delivers a better-than-expected Q2, largely driven by strength in CALID Group and BEST. Moreover, a raised guidance buoys optimism.

                                                Zacks Equity Research

                                                Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth

                                                by Zacks Equity Research

                                                Waters Corp. (WAT) second-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Asia.

                                                  Zacks Equity Research

                                                  Here's Why Investors Should Invest in Bruker (BRKR) Now

                                                  by Zacks Equity Research

                                                  With solid growth prospects, Bruker Corporation (BRKR) carries a Zacks Rank #2 (Buy) and is an attractive pick at present.